Ruxolitinib (S) Size:Solid 2 mg 2 µM）and human primary islets

SKU: 61854456478

Pay in 4 interest-free payments of $31.50 Learn more

Live Spec

Ruxolitinib (S) Size:Solid 2 mg 2 µM）and human primary isletsS Ruxolitinib is a less active enantiomer of Ruxolitinib, a JAK1 2 inhibitor. S Ruxolitinib was initially developed to target the constitutive activation of the JAK STAT pathway. Janus kinases (JAKs) are a family of cytoplasmic tyrosine kinases that mediates signals from the receptors for various cytokines and growth factors that have a key role in haematopoiesis and immune function. Ruxolitinib maintains its anti JAK activity by competitive

Store: avramcheva.com · Domain: avramcheva.com